Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Monks

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Carcinogenesis|February 24, 1998
2-Hydroxy-4-glutathion-S-yl-17beta-estradiol and 2-hydroxy-1-glutathion-S-yl-17beta-estradiol produce oxidative stress and renal toxicity in an animal model of 17beta-estradiol-mediated nephrocarcinogenicityM Butterworth, S S Lau, T J Monks
Carcinogenesis|March 1, 1997
Formation of catechol estrogen glutathione conjugates and gamma-glutamyl transpeptidase-dependent nephrotoxicity of 17beta-estradiol in the golden Syrian hamsterM Butterworth, S S Lau, T J Monks
British Journal of Pharmacology|June 1, 1978
A comparison of the metabolism and pharmacokinetics of intravenously administered theophylline and aminophylline in man [proceedings]J Caldwell, T J Monks, R L Smith
Biopharmaceutics & Drug Disposition|January 1, 1981
The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in manT J Monks, C A Lawrie, J Caldwell
Clinical Pharmacology and Therapeutics|October 1, 1979
Influence of methylxanthine-containing foods on theophylline metabolism and kineticsT J Monks, J Caldwell, R L Smith
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylationS S Lau, H E Kleiner, T J Monks
Molecular Pharmacology|July 1, 1990
Oxidative cyclization, 1,4-benzothiazine formation and dimerization of 2-bromo-3-(glutathion-S-yl)hydroquinoneT J Monks, R J Highet, S S Lau
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1984
Identification of 2-bromohydroquinone as a metabolite of bromobenzene and o-bromophenol: implications for bromobenzene-induced nephrotoxicityS S Lau, T J Monks, J R Gillette
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzeneT J Monks, S S Lau, J R Gillette
Toxicology and Applied Pharmacology|December 1, 1992
The effects of 2,3,5-(triglutathion-S-yl)hydroquinone on renal mitochondrial respiratory function in vivo and in vitro: possible role in cytotoxicityB A Hill, T J Monks, S S Lau
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Carcinogenesis|February 24, 1998
2-Hydroxy-4-glutathion-S-yl-17beta-estradiol and 2-hydroxy-1-glutathion-S-yl-17beta-estradiol produce oxidative stress and renal toxicity in an animal model of 17beta-estradiol-mediated nephrocarcinogenicityM Butterworth, S S Lau, T J Monks
Carcinogenesis|March 1, 1997
Formation of catechol estrogen glutathione conjugates and gamma-glutamyl transpeptidase-dependent nephrotoxicity of 17beta-estradiol in the golden Syrian hamsterM Butterworth, S S Lau, T J Monks
British Journal of Pharmacology|June 1, 1978
A comparison of the metabolism and pharmacokinetics of intravenously administered theophylline and aminophylline in man [proceedings]J Caldwell, T J Monks, R L Smith
Biopharmaceutics & Drug Disposition|January 1, 1981
The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in manT J Monks, C A Lawrie, J Caldwell
Clinical Pharmacology and Therapeutics|October 1, 1979
Influence of methylxanthine-containing foods on theophylline metabolism and kineticsT J Monks, J Caldwell, R L Smith
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylationS S Lau, H E Kleiner, T J Monks
Molecular Pharmacology|July 1, 1990
Oxidative cyclization, 1,4-benzothiazine formation and dimerization of 2-bromo-3-(glutathion-S-yl)hydroquinoneT J Monks, R J Highet, S S Lau
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1984
Identification of 2-bromohydroquinone as a metabolite of bromobenzene and o-bromophenol: implications for bromobenzene-induced nephrotoxicityS S Lau, T J Monks, J R Gillette
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzeneT J Monks, S S Lau, J R Gillette
Toxicology and Applied Pharmacology|December 1, 1992
The effects of 2,3,5-(triglutathion-S-yl)hydroquinone on renal mitochondrial respiratory function in vivo and in vitro: possible role in cytotoxicityB A Hill, T J Monks, S S Lau
Pageof 10